Cardinal Health (0HTG) Ownership - Who Owns Cardinal Health?
Cardinal Health (0HTG) Ownership Overview
- 0.25% Insiders
- 24.66% Mutual Funds
- 3.23% Other Institutional Investors
- 30.38% ETFs
- 41.48% Public Companies and Individual Investors
The ownership structure of Cardinal Health (GB:0HTG) stock is a mix of institutional, retail, and individual investors. Approximately 58.27% of the company’s stock is owned by Institutional Investors, 0.25% is owned by Insiders, and 41.48% is owned by Public Companies and Individual Investors.
The ownership structure of Cardinal Health (GB:0HTG) stock is a mix of institutional, retail, and individual investors. Approximately 58.27% of the company’s stock is owned by Institutional Investors, 0.25% is owned by Insiders, and 41.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 19, 2026 | Stephen M Mason | $8,274,117 | |
| Aug 19, 2026 | Michelle D. Greene | $2,746,187 | |
| Aug 19, 2026 | Aaron E Alt | $9,926,140 | |
| Aug 19, 2026 | Jessica L Mayer | $6,952,485 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Manning & Napier Advisors Llc | $2,055 | |
| Dec 31, 2025 | Entrypoint Capital, Llc | $389,628 | |
| Dec 31, 2025 | Fisher Asset Management Llc | $476,554 | |
| Dec 31, 2025 | First Eagle Investment Management Llc | $1,444,459 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 27,206,561 | Institution | 11.75% | 6,820,956,908 |
| Vanguard Index Funds | 22,582,681 | Institution | 9.75% | 5,661,703,954 |
| Ishares | 14,212,551 | Institution | 6.14% | 3,563,228,661 |
| Spdr | 9,926,960 | Institution | 4.29% | 2,488,788,142 |
| Vanguard Specialized Funds | 4,706,400 | Institution | 2.03% | 1,179,941,544 |
| Fidelity Concord Street Trust | 4,118,040 | Institution | 1.78% | 1,032,433,808 |
| Invesco | 3,566,887 | Institution | 1.54% | 894,254,240 |
| Xtrackers | 3,417,094 | Institution | 1.48% | 856,699,637 |
| Amundi | 3,007,791 | Institution | 1.30% | 754,083,282 |
| Vanguard Fenway Funds | 2,636,282 | Institution | 1.14% | 660,942,260 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 22,582,681 | Institution | 9.75% | 5,661,703,954 |
| Vanguard Specialized Funds | 4,706,400 | Institution | 2.03% | 1,179,941,544 |
| Fidelity Concord Street Trust | 4,118,040 | Institution | 1.78% | 1,032,433,808 |
| Vanguard Fenway Funds | 2,636,282 | Institution | 1.14% | 660,942,260 |
| Vanguard Wellington Fund | 2,169,583 | Institution | 0.94% | 543,936,154 |
| Tiaa-cref Funds | 1,811,325 | Institution | 0.78% | 454,117,291 |
| Vanguard Institutional Index Funds | 1,383,258 | Institution | 0.60% | 346,796,613 |
| Fidelity Salem Street Trust | 1,336,784 | Institution | 0.58% | 335,145,117 |
| Vanguard Whitehall Funds | 946,771 | Institution | 0.41% | 237,364,957 |
| Schwab Capital Trust | 870,010 | Institution | 0.38% | 218,120,207 |
FAQ
Who Owns Cardinal Health (GB:0HTG)?
According to the latest TipRanks data, approximately 58.27% of the company's stock is held by institutional investors, 0.25% is held by insiders, and 41.48% is held by public companies and individual investors.
What percentage of Cardinal Health (GB:0HTG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 58.27% of Cardinal Health (GB:0HTG) stock is held by institutional investors: 24.66% by mutual funds, 30.38% by ETFs and 3.23% by other institutional investors.
What percentage of Cardinal Health (GB:0HTG) stock is held by retail investors?
According to the latest TipRanks data, approximately 41.48% of Cardinal Health (GB:0HTG) stock is held by public companies and individual investors.
Who owns the most shares of Cardinal Health (GB:0HTG)?
Vanguard owns the most shares of Cardinal Health (GB:0HTG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.